Novo Nordisk: raises outlook on posting earnings growth
(CercleFinance.com) - Novo Nordisk has announced that its sales reached 83.
3 billion Danish kronor in the first half of the year, up 16% y-o-y at constant exchange rates.
At the same time, EBUT increased by 14% at constant exchange rates to 37.5 Danish kronor.
Novo Nordisk finally reported earnings that are up 11% at 27.5 billion Danish kronor with EPS up 13% at 12.08 Danish kronor.
Following this release, Novo Nordisk has raised its outlook for FY 2022, targeting sales growth of 12%-16% at constant exchange rates.
Copyright (c) 2022 CercleFinance.com. All rights reserved.